Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP703540.RABQQ9l5LwNv799CTvt_cPe29u7DejOEM3UHIbVBLen4A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP703540.RABQQ9l5LwNv799CTvt_cPe29u7DejOEM3UHIbVBLen4A130_assertion type Assertion NP703540.RABQQ9l5LwNv799CTvt_cPe29u7DejOEM3UHIbVBLen4A130_head.
- NP703540.RABQQ9l5LwNv799CTvt_cPe29u7DejOEM3UHIbVBLen4A130_assertion description "[Somatic mutations in the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene are associated with sensitivity of lung adenocarcinomas to the EGFR tyrosine kinase inhibitors, gefitinib and erlotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703540.RABQQ9l5LwNv799CTvt_cPe29u7DejOEM3UHIbVBLen4A130_provenance.
- NP703540.RABQQ9l5LwNv799CTvt_cPe29u7DejOEM3UHIbVBLen4A130_assertion evidence source_evidence_literature NP703540.RABQQ9l5LwNv799CTvt_cPe29u7DejOEM3UHIbVBLen4A130_provenance.
- NP703540.RABQQ9l5LwNv799CTvt_cPe29u7DejOEM3UHIbVBLen4A130_assertion SIO_000772 19010870 NP703540.RABQQ9l5LwNv799CTvt_cPe29u7DejOEM3UHIbVBLen4A130_provenance.
- NP703540.RABQQ9l5LwNv799CTvt_cPe29u7DejOEM3UHIbVBLen4A130_assertion wasDerivedFrom befree-2016 NP703540.RABQQ9l5LwNv799CTvt_cPe29u7DejOEM3UHIbVBLen4A130_provenance.
- NP703540.RABQQ9l5LwNv799CTvt_cPe29u7DejOEM3UHIbVBLen4A130_assertion wasGeneratedBy ECO_0000203 NP703540.RABQQ9l5LwNv799CTvt_cPe29u7DejOEM3UHIbVBLen4A130_provenance.